Paper alert 🤩 stoked about publishing our story on transcriptional heterogeneity of breast cancer, profiling primary tumors and their matched metastases at single-cell resolution. out today in @jclinicalinvest https://t.co/34RlObTnIS. check out the 🧵of the pre-print 👇 1/n
How does tumor heterogeneity impact #metastasis?
I am excited to share our latest pre-print: We used patient derived-xenograft models (PDX) of #breastcancer to examine the contributions of tumor heterogeneity on metastasis at single-cell resolution.
https://t.co/wQwKeFpQhb
1/n
#ProudPI another graduation from our lab: celebrating Godfrey’s bachelor’s degree 🥳 with a special cup with one of his beautiful IF stains 🔬 well done and congratulations Mr. BSc
Join me in Graz on Sept 16-19th for the 🧬🔬🧪🧫Austrian Association of Molecular Life Sciences and Biotechnology (ÖGMBT) annual meeting! Submit your abstract now 👉https://t.co/MMPhRlaJJh
Super excited to welcome @AnnaLenaDeSouza, who joined my lab this week as a PhD candidate! She recently finished her Master's in Health Science and Radiation Biology. Have a good start and let's grow some #organoids. 👩🔬🧫
Paper alert 🤩 stoked about publishing our story on transcriptional heterogeneity of breast cancer, profiling primary tumors and their matched metastases at single-cell resolution. out today in @jclinicalinvest https://t.co/34RlObTnIS. check out the 🧵of the pre-print 👇 1/n
How does tumor heterogeneity impact #metastasis?
I am excited to share our latest pre-print: We used patient derived-xenograft models (PDX) of #breastcancer to examine the contributions of tumor heterogeneity on metastasis at single-cell resolution.
https://t.co/wQwKeFpQhb
1/n
Paper 🚨! Ecstatic, proud, grateful …Years of dedication from the whole lab, with the exceptional @djkloosterman and the one of a kind #JohannaErbani at its helm. What a journey all the way to @CellCellPress! How did it start (& end)? A 🧵1/n
https://t.co/d1SPgjFRDr